Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 4 | 2025 | 735 | 0.690 |
Why?
|
| Glucosylceramidase | 2 | 2024 | 33 | 0.580 |
Why?
|
| Cathepsin D | 1 | 2017 | 16 | 0.540 |
Why?
|
| Acid Ceramidase | 1 | 2017 | 7 | 0.540 |
Why?
|
| Organic Anion Transporters | 1 | 2017 | 23 | 0.530 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2017 | 42 | 0.530 |
Why?
|
| Symporters | 1 | 2017 | 80 | 0.510 |
Why?
|
| Intellectual Disability | 5 | 2024 | 1089 | 0.370 |
Why?
|
| Receptors, Cell Surface | 3 | 2009 | 420 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2025 | 3436 | 0.350 |
Why?
|
| Myelin Proteins | 2 | 2009 | 78 | 0.300 |
Why?
|
| Nervous System Malformations | 2 | 2022 | 135 | 0.300 |
Why?
|
| Syndrome | 5 | 2024 | 1155 | 0.300 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2009 | 6 | 0.300 |
Why?
|
| Exome | 6 | 2024 | 1061 | 0.280 |
Why?
|
| Central Nervous System | 1 | 2009 | 269 | 0.260 |
Why?
|
| Seizures | 2 | 2024 | 890 | 0.240 |
Why?
|
| Mutation | 6 | 2022 | 6099 | 0.240 |
Why?
|
| Genetic Variation | 4 | 2024 | 1559 | 0.230 |
Why?
|
| Chaperonin Containing TCP-1 | 1 | 2024 | 9 | 0.220 |
Why?
|
| Mutation, Missense | 3 | 2019 | 919 | 0.220 |
Why?
|
| Williams Syndrome | 1 | 2024 | 42 | 0.210 |
Why?
|
| Dynamins | 3 | 2019 | 51 | 0.210 |
Why?
|
| Protein Folding | 1 | 2024 | 214 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 619 | 0.200 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 266 | 0.190 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 151 | 0.180 |
Why?
|
| Zebrafish | 1 | 2024 | 418 | 0.180 |
Why?
|
| GTP Phosphohydrolases | 3 | 2019 | 155 | 0.180 |
Why?
|
| Nuclear Proteins | 2 | 2019 | 1211 | 0.170 |
Why?
|
| Aniridia | 1 | 2021 | 11 | 0.170 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 27 | 0.170 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 61 | 0.160 |
Why?
|
| Zika Virus | 1 | 2022 | 150 | 0.160 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 819 | 0.160 |
Why?
|
| Introns | 1 | 2021 | 278 | 0.160 |
Why?
|
| Zika Virus Infection | 1 | 2022 | 173 | 0.160 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 37 | 0.150 |
Why?
|
| Peroxisomes | 2 | 2019 | 42 | 0.150 |
Why?
|
| Drosophila melanogaster | 3 | 2025 | 789 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 63 | 0.150 |
Why?
|
| Microcephaly | 1 | 2022 | 347 | 0.150 |
Why?
|
| Case-Control Studies | 3 | 2025 | 3359 | 0.150 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2018 | 10 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2018 | 248 | 0.140 |
Why?
|
| Mitochondria | 3 | 2022 | 785 | 0.140 |
Why?
|
| Mitochondrial Proteins | 2 | 2018 | 283 | 0.130 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 56 | 0.130 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2017 | 41 | 0.130 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 781 | 0.130 |
Why?
|
| Phenotype | 6 | 2024 | 4497 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2024 | 1106 | 0.130 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 110 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 137 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2019 | 299 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 119 | 0.120 |
Why?
|
| Tenascin | 1 | 2016 | 33 | 0.120 |
Why?
|
| Humans | 24 | 2025 | 131163 | 0.120 |
Why?
|
| Male | 14 | 2025 | 64957 | 0.110 |
Why?
|
| Autistic Disorder | 1 | 2019 | 398 | 0.110 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 76 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 219 | 0.110 |
Why?
|
| Brain | 2 | 2024 | 3175 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 963 | 0.110 |
Why?
|
| GPI-Linked Proteins | 3 | 2009 | 110 | 0.100 |
Why?
|
| Spasms, Infantile | 1 | 2016 | 166 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 280 | 0.100 |
Why?
|
| Alleles | 4 | 2021 | 1673 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 4697 | 0.100 |
Why?
|
| Female | 13 | 2025 | 70963 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 500 | 0.100 |
Why?
|
| Adult | 8 | 2024 | 31282 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 468 | 0.100 |
Why?
|
| Chromatin | 1 | 2016 | 499 | 0.100 |
Why?
|
| Histones | 1 | 2016 | 541 | 0.090 |
Why?
|
| Nogo Receptor 1 | 2 | 2009 | 7 | 0.090 |
Why?
|
| Aged | 5 | 2025 | 21025 | 0.090 |
Why?
|
| Genotype | 1 | 2017 | 2595 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2017 | 5063 | 0.080 |
Why?
|
| Animals | 9 | 2025 | 33912 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 1692 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1833 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 40 | 0.070 |
Why?
|
| Prosencephalon | 1 | 2009 | 39 | 0.070 |
Why?
|
| Neurites | 1 | 2009 | 43 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 159 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1889 | 0.070 |
Why?
|
| Dendritic Spines | 1 | 2008 | 56 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 83 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2008 | 69 | 0.060 |
Why?
|
| Middle Aged | 4 | 2024 | 28601 | 0.060 |
Why?
|
| Infant | 5 | 2024 | 13352 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 787 | 0.060 |
Why?
|
| Transfection | 1 | 2009 | 962 | 0.060 |
Why?
|
| Myelin Sheath | 1 | 2008 | 131 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2009 | 516 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6797 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1105 | 0.060 |
Why?
|
| Binding Sites | 1 | 2009 | 1133 | 0.060 |
Why?
|
| Rats | 2 | 2009 | 3370 | 0.060 |
Why?
|
| Adolescent | 5 | 2024 | 20987 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1021 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2008 | 283 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2024 | 15110 | 0.060 |
Why?
|
| Replication Protein C | 1 | 2024 | 5 | 0.050 |
Why?
|
| Neurons | 2 | 2017 | 1979 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2008 | 273 | 0.050 |
Why?
|
| Synapses | 1 | 2008 | 425 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2024 | 133 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2024 | 157 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 2395 | 0.050 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 143 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2024 | 133 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 86 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 177 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 251 | 0.050 |
Why?
|
| Proteome | 1 | 2024 | 285 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 317 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3763 | 0.040 |
Why?
|
| Drosophila | 1 | 2025 | 739 | 0.040 |
Why?
|
| Facies | 1 | 2021 | 157 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 110 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2024 | 849 | 0.040 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 20 | 0.040 |
Why?
|
| Child | 4 | 2024 | 26341 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2025 | 718 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 775 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 57 | 0.040 |
Why?
|
| Germ Cells | 1 | 2020 | 201 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 362 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 197 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 160 | 0.030 |
Why?
|
| Infant Care | 1 | 2017 | 45 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 4738 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1103 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 712 | 0.030 |
Why?
|
| White Matter | 1 | 2020 | 219 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 10103 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 737 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2017 | 200 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 187 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 190 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 167 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2017 | 237 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2016 | 226 | 0.030 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 194 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 1621 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2016 | 156 | 0.030 |
Why?
|
| Face | 1 | 2016 | 192 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 726 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 801 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 623 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 252 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 258 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1571 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 558 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2017 | 8635 | 0.020 |
Why?
|
| Mice | 3 | 2017 | 18301 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2552 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 1677 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 686 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1421 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2016 | 993 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 11074 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4886 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3686 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3819 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1939 | 0.020 |
Why?
|
| Nogo Receptor 2 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Nogo Proteins | 1 | 2008 | 8 | 0.020 |
Why?
|
| Growth Cones | 1 | 2008 | 15 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2008 | 35 | 0.020 |
Why?
|
| COS Cells | 1 | 2008 | 253 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2008 | 101 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2008 | 60 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 356 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 4686 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1652 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2885 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 17753 | 0.010 |
Why?
|